IONS logo

Ionis Pharmaceuticals (IONS) Long term debt

Annual long term debt:

$1.41B+$6.91M(+0.49%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual long term debt is $1.41 billion, with the most recent change of +$6.91 million (+0.49%) on December 31, 2024.
  • During the last 3 years, IONS annual long term debt has risen by +$159.77 million (+12.81%).
  • IONS annual long term debt is now at all-time high.

Performance

IONS Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

Quarterly long term debt:

$1.41B+$2.82M(+0.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly long term debt is $1.41 billion, with the most recent change of +$2.82 million (+0.20%) on March 31, 2025.
  • Over the past year, IONS quarterly long term debt has increased by +$10.51 million (+0.75%).
  • IONS quarterly long term debt is now -5.38% below its all-time high of $1.49 billion, reached on June 30, 2023.

Performance

IONS Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

IONS Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.5%+0.8%
3 y3 years+12.8%+15.4%
5 y5 years+82.8%+80.9%

IONS Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+12.8%-5.4%+15.4%
5 y5-yearat high+134.5%-5.4%+135.0%
alltimeall timeat high>+9999.0%-5.4%>+9999.0%

IONS Long term debt History

DateAnnualQuarterly
Mar 2025
-
$1.41B(+0.2%)
Dec 2024
$1.41B(+0.5%)
$1.41B(+0.4%)
Sep 2024
-
$1.40B(+0.2%)
Jun 2024
-
$1.40B(-0.1%)
Mar 2024
-
$1.40B(-0.1%)
Dec 2023
$1.40B(+2.8%)
$1.40B(-3.6%)
Sep 2023
-
$1.45B(-2.5%)
Jun 2023
-
$1.49B(+9.5%)
Mar 2023
-
$1.36B(-0.0%)
Dec 2022
$1.36B(+9.1%)
$1.36B(+11.2%)
Sep 2022
-
$1.22B(+0.1%)
Jun 2022
-
$1.22B(+0.1%)
Mar 2022
-
$1.22B(-2.0%)
Dec 2021
$1.25B(+107.9%)
$1.25B(+2.3%)
Sep 2021
-
$1.22B(+0.1%)
Jun 2021
-
$1.22B(+43.7%)
Mar 2021
-
$847.97M(+41.3%)
Dec 2020
$600.12M(-22.1%)
$600.12M(-24.9%)
Sep 2020
-
$798.93M(+1.2%)
Jun 2020
-
$789.18M(+1.2%)
Mar 2020
-
$779.59M(+1.3%)
Dec 2019
$769.96M(+22.6%)
$769.96M(+17.3%)
Sep 2019
-
$656.25M(+1.5%)
Jun 2019
-
$646.67M(+1.5%)
Mar 2019
-
$637.27M(+1.5%)
Dec 2018
$628.06M(+5.9%)
$628.06M(+1.5%)
Sep 2018
-
$619.01M(+1.5%)
Jun 2018
-
$610.13M(+1.4%)
Mar 2018
-
$601.42M(+1.4%)
Dec 2017
$592.88M(+3.5%)
$592.88M(+1.4%)
Sep 2017
-
$584.49M(+3.0%)
Jun 2017
-
$567.56M(-2.3%)
Mar 2017
-
$580.81M(+1.4%)
Dec 2016
$572.87M(+24.1%)
$572.87M(+19.3%)
Sep 2016
-
$480.33M(+1.3%)
Jun 2016
-
$473.96M(+1.3%)
Mar 2016
-
$467.71M(+1.3%)
Dec 2015
$461.59M(+3.2%)
$461.59M(-0.5%)
Sep 2015
-
$463.98M(+1.2%)
Jun 2015
-
$458.29M(+1.2%)
Mar 2015
-
$452.70M(+1.2%)
Dec 2014
$447.23M(+101.8%)
$447.23M(+97.0%)
Sep 2014
-
$227.05M(+0.8%)
Jun 2014
-
$225.20M(+0.8%)
Mar 2014
-
$223.40M(+0.8%)
Dec 2013
$221.62M(+3.3%)
$221.62M(+0.8%)
Sep 2013
-
$219.80M(+0.8%)
Jun 2013
-
$218.01M(+0.8%)
Mar 2013
-
$216.26M(+0.8%)
Dec 2012
$214.54M(+1.5%)
$214.54M(-3.0%)
Sep 2012
-
$221.28M(-2.0%)
Jun 2012
-
$225.74M(+3.9%)
Mar 2012
-
$217.36M(+2.9%)
Dec 2011
$211.32M(+42.1%)
$211.32M(-0.7%)
Sep 2011
-
$212.86M(+5.8%)
Jun 2011
-
$201.26M(+34.1%)
Mar 2011
-
$150.05M(+0.9%)
Dec 2010
$148.76M(+8.9%)
$148.76M(+2.4%)
Sep 2010
-
$145.33M(+0.5%)
Jun 2010
-
$144.67M(+2.2%)
Mar 2010
-
$141.61M(+3.7%)
Dec 2009
$136.58M(-20.8%)
$136.58M(+0.6%)
Sep 2009
-
$135.80M(+2.8%)
Jun 2009
-
$132.11M(+0.8%)
Mar 2009
-
$131.08M(-24.0%)
Dec 2008
$172.44M(+5.9%)
$172.44M(+2.7%)
Sep 2008
-
$167.98M(+0.0%)
Jun 2008
-
$167.91M(+3.1%)
Mar 2008
-
$162.89M(+0.0%)
DateAnnualQuarterly
Dec 2007
$162.86M(+22.6%)
$162.86M(-1.1%)
Sep 2007
-
$164.72M(-1.1%)
Jun 2007
-
$166.55M(-1.1%)
Mar 2007
-
$168.39M(+26.8%)
Dec 2006
$132.82M(-5.1%)
$132.82M(-1.4%)
Sep 2006
-
$134.74M(-1.1%)
Jun 2006
-
$136.17M(-1.3%)
Mar 2006
-
$137.94M(-1.4%)
Dec 2005
$139.91M(-40.9%)
$139.91M(-1.4%)
Sep 2005
-
$141.84M(-42.0%)
Jun 2005
-
$244.43M(+0.4%)
Mar 2005
-
$243.36M(+2.9%)
Dec 2004
$236.61M(+10.9%)
$236.61M(+3.2%)
Sep 2004
-
$229.37M(+2.4%)
Jun 2004
-
$224.03M(+2.0%)
Mar 2004
-
$219.56M(+2.9%)
Dec 2003
$213.40M(+3.0%)
$213.40M(+12.7%)
Sep 2003
-
$189.39M(-0.4%)
Jun 2003
-
$190.22M(-4.9%)
Mar 2003
-
$199.95M(-3.5%)
Dec 2002
$207.26M(+64.9%)
$207.26M(+15.9%)
Sep 2002
-
$178.84M(-6.7%)
Jun 2002
-
$191.66M(+43.1%)
Mar 2002
-
$133.92M(+6.5%)
Dec 2001
$125.71M(+22.9%)
$125.71M(+1.7%)
Sep 2001
-
$123.65M(+6.9%)
Jun 2001
-
$115.67M(+10.7%)
Mar 2001
-
$104.45M(+2.2%)
Dec 2000
$102.25M(+17.1%)
$102.25M(+6.1%)
Sep 2000
-
$96.33M(+1.9%)
Jun 2000
-
$94.50M(+3.5%)
Mar 2000
-
$91.30M(+4.6%)
Dec 1999
$87.30M(+12.4%)
$87.30M(+1.7%)
Sep 1999
-
$85.80M(+4.3%)
Jun 1999
-
$82.30M(+4.3%)
Mar 1999
-
$78.90M(+1.5%)
Dec 1998
$77.70M(+37.5%)
$77.70M(+5.1%)
Sep 1998
-
$73.90M(+2.8%)
Jun 1998
-
$71.90M(+26.8%)
Mar 1998
-
$56.70M(+0.4%)
Dec 1997
$56.50M(+183.9%)
$56.50M(+65.7%)
Sep 1997
-
$34.10M(+1.8%)
Jun 1997
-
$33.50M(+69.2%)
Mar 1997
-
$19.80M(-0.5%)
Dec 1996
$19.90M(+323.4%)
$19.90M(+298.0%)
Sep 1996
-
$5.00M(+2.0%)
Jun 1996
-
$4.90M(-7.5%)
Mar 1996
-
$5.30M(+12.8%)
Dec 1995
$4.70M(-49.5%)
$4.70M(-41.3%)
Sep 1995
-
$8.00M(-4.8%)
Jun 1995
-
$8.40M(-5.6%)
Mar 1995
-
$8.90M(-4.3%)
Dec 1994
$9.30M(+5.7%)
$9.30M(-4.1%)
Sep 1994
-
$9.70M(+21.3%)
Jun 1994
-
$8.00M(-4.8%)
Mar 1994
-
$8.40M(-4.5%)
Dec 1993
$8.80M(+31.3%)
$8.80M(+7.3%)
Sep 1993
-
$8.20M(+15.5%)
Jun 1993
-
$7.10M(+7.6%)
Mar 1993
-
$6.60M(-1.5%)
Dec 1992
$6.70M(+34.0%)
$6.70M(-1.5%)
Sep 1992
-
$6.80M(+1.5%)
Jun 1992
-
$6.70M(+19.6%)
Mar 1992
-
$5.60M(+12.0%)
Dec 1991
$5.00M(+455.6%)
$5.00M(+61.3%)
Sep 1991
-
$3.10M(+6.9%)
Jun 1991
-
$2.90M(+190.0%)
Mar 1991
-
$1.00M(+11.1%)
Dec 1990
$900.00K
$900.00K

FAQ

  • What is Ionis Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual long term debt year-on-year change?
  • What is Ionis Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly long term debt year-on-year change?

What is Ionis Pharmaceuticals annual long term debt?

The current annual long term debt of IONS is $1.41B

What is the all time high annual long term debt for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual long term debt is $1.41B

What is Ionis Pharmaceuticals annual long term debt year-on-year change?

Over the past year, IONS annual long term debt has changed by +$6.91M (+0.49%)

What is Ionis Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of IONS is $1.41B

What is the all time high quarterly long term debt for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly long term debt is $1.49B

What is Ionis Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, IONS quarterly long term debt has changed by +$10.51M (+0.75%)
On this page